A detailed history of Pioneer Trust Bank N A transactions in Abb Vie Inc. stock. As of the latest transaction made, Pioneer Trust Bank N A holds 4,145 shares of ABBV stock, worth $714,266. This represents 0.21% of its overall portfolio holdings.

Number of Shares
4,145
Previous 4,245 2.36%
Holding current value
$714,266
Previous $657,000 14.76%
% of portfolio
0.21%
Previous 0.2%

Shares

23 transactions
Quarter Operation Price Per share shares change shares Held SEC Form
Q1 2024

Apr 25, 2024

SELL
$159.82 - $182.1 $15,982 - $18,210
-100 Reduced 2.36%
4,145 $754,000
Q2 2023

Jul 11, 2023

SELL
$132.51 - $164.9 $31,802 - $39,576
-240 Reduced 5.35%
4,245 $571,000
Q1 2023

Apr 24, 2023

SELL
$144.61 - $166.54 $21,691 - $24,981
-150 Reduced 3.24%
4,485 $714,000
Q3 2022

Oct 31, 2022

SELL
$134.21 - $153.93 $89,249 - $102,363
-665 Reduced 12.55%
4,635 $622,000
Q2 2022

Aug 10, 2022

SELL
$137.62 - $174.96 $19,954 - $25,369
-145 Reduced 2.66%
5,300 $812,000
Q1 2022

May 10, 2022

SELL
$131.98 - $163.75 $28,375 - $35,206
-215 Reduced 3.8%
5,445 $883,000
Q4 2021

Jan 18, 2022

BUY
$107.43 - $135.93 $10,743 - $13,593
100 Added 1.8%
5,660 $766,000
Q2 2021

Jul 19, 2021

SELL
$105.21 - $117.21 $200,319 - $223,167
-1,904 Reduced 25.51%
5,560 $626,000
Q1 2021

Apr 15, 2021

SELL
$102.3 - $112.62 $102 - $112
-1 Reduced 0.01%
7,464 $807,000
Q4 2020

Jan 15, 2021

BUY
$80.49 - $108.67 $20,122 - $27,167
250 Added 3.47%
7,465 $800,000
Q3 2020

Oct 19, 2020

SELL
$85.91 - $100.83 $30,068 - $35,290
-350 Reduced 4.63%
7,215 $632,000
Q2 2020

Jul 23, 2020

SELL
$73.37 - $98.18 $64,932 - $86,889
-885 Reduced 10.47%
7,565 $742,000
Q1 2020

Apr 15, 2020

SELL
$64.5 - $97.79 $57,082 - $86,544
-885 Reduced 9.48%
8,450 $644,000
Q4 2019

Jan 24, 2020

SELL
$72.13 - $90.25 $125,650 - $157,215
-1,742 Reduced 15.73%
9,335 $826,000
Q3 2019

Oct 18, 2019

SELL
$62.98 - $75.72 $1.55 Million - $1.87 Million
-24,665 Reduced 69.01%
11,077 $839,000
Q2 2019

Jul 19, 2019

SELL
$65.7 - $83.98 $348,932 - $446,017
-5,311 Reduced 12.94%
35,742 $2.6 Million
Q1 2019

Apr 04, 2019

SELL
$77.14 - $90.79 $580,632 - $683,376
-7,527 Reduced 15.49%
41,053 $3.31 Million
Q4 2018

Jan 23, 2019

BUY
$77.85 - $96.01 $42,039 - $51,845
540 Added 1.12%
48,580 $4.48 Million
Q3 2018

Oct 10, 2018

BUY
$88.91 - $98.84 $85,798 - $95,380
965 Added 2.05%
48,040 $4.54 Million
Q2 2018

Jul 19, 2018

SELL
$89.78 - $106.23 $21,996 - $26,026
-245 Reduced 0.52%
47,075 $4.36 Million
Q1 2018

Apr 18, 2018

SELL
$92.01 - $123.21 $226,344 - $303,096
-2,460 Reduced 4.94%
47,320 $4.48 Million
Q4 2017

Jan 19, 2018

SELL
$89.56 - $98.21 $55,079 - $60,399
-615 Reduced 1.22%
49,780 $4.81 Million
Q3 2017

Oct 11, 2017

BUY
$69.85 - $89.22 $3.52 Million - $4.5 Million
50,395
50,395 $4.48 Million

Others Institutions Holding ABBV

About AbbVie Inc.


  • Ticker ABBV
  • Exchange NYSE
  • Sector Healthcare
  • Industry Drug Manufacturers—General
  • Shares Outstandng 1,768,099,968
  • Market Cap $305B
  • Description
  • AbbVie Inc. discovers, develops, manufactures, and sells pharmaceuticals in the worldwide. The company offers HUMIRA, a therapy administered as an injection for autoimmune and intestinal Behçet's diseases; SKYRIZI to treat moderate to severe plaque psoriasis in adults; RINVOQ, a JAK inhibitor for the treatment of moderate to severe active rheuma...
More about ABBV
Track This Portfolio

Track Pioneer Trust Bank N A Portfolio

Follow Pioneer Trust Bank N A and customize your updates to receive the information that matters most to you.

Portfolio Update

Get notified when there are updates to the investment portfolio of Pioneer Trust Bank N A, based on Form 13F filings with the SEC.

News

Stay updated on Pioneer Trust Bank N A with notifications on news.